Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Bioscience Reports|April 23, 2026
Small-molecule inhibitor of Gαo for GNAO1 encephalopathyYonika A Larasati, Alexey Koval, Vladimir L Katanaev
Cells|April 25, 2025
A Personalized 14-3-3 Disease-Targeting Workflow Yields Repositioning Drug CandidatesYonika A Larasati, Gonzalo P Solis, Alexey Koval, et al.
Med (New York, N.Y.)|August 17, 2024
Zinc for GNAO1 encephalopathy: Preclinical profiling and a clinical caseYonika A Larasati, Moritz Thiel, Alexey Koval, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2024
GNAO1 Mutations Affecting the N-Terminal α-Helix of Gαo Lead to ParkinsonismGonzalo P Solis, Yonika A Larasati, Moritz Thiel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 29, 2025
Pathogenic Gαo Mutants Drive Dominant GPCR Coupling in GNAO1 EncephalopathiesYonika A Larasati, Camille Rabesahala de Meritens, Miriam Stoeber, et al.
Med (New York, N.Y.)|March 31, 2023
In-depth molecular profiling of an intronic GNAO1 mutant as the basis for personalized high-throughput drug screeningAlexey Koval, Yonika A Larasati, Mikhail Savitsky, et al.
Molecular Autism|December 12, 2025
Atypical GNAO1 variants in severe childhood speech disorders: clinical, genetic, and molecular insightsYonika A Larasati, Moritz Thiel, Ainara Salazar-Villacorta, et al.
Cells|October 27, 2023
Clinical Cases and the Molecular Profiling of a Novel Childhood Encephalopathy-Causing <i>GNAO1</i> Mutation P170RYonika A Larasati, Gonzalo P Solis, Alexey Koval, et al.
Pageof 2